The word longevity has been taken over by marketers. It now appears on everything from collagen drinks to sleep trackers to adaptogenic mushroom coffees. Most of it is noise. But beneath the noise, there is a serious and growing body of science. And some of what that science suggests is genuinely actionable.
This is not about living to 150. It is about the quality of the decades you already have. The field that matters here is not lifespan. It is healthspan: the number of years you spend in good health, with full cognitive and physical function.
The Hallmarks of Ageing
In 2013, a landmark paper published in Cell identified nine hallmarks of ageing, biological processes that accumulate over time and drive the deterioration we associate with growing old. These include genomic instability (DNA damage that is not fully repaired), telomere shortening, epigenetic alterations, loss of proteostasis (the cell's ability to manage protein quality), deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication.
The hallmarks are not independent. They interact. Mitochondrial dysfunction accelerates cellular senescence. Senescent cells disrupt intercellular communication. Understanding this interconnection is why serious longevity research focuses on foundational cellular mechanisms rather than single-target interventions.
What the Evidence Supports
Of the interventions studied in human trials, a small number stand out for having both mechanistic plausibility and clinical data.
NAD+ restoration. NAD+ is essential for mitochondrial function and sirtuin activity. It declines significantly with age. NR and NMN, two NAD+ precursors, have been shown in human trials to raise NAD+ levels. The downstream effects on energy and cellular repair are biologically coherent, though long-term human data is still accumulating.
Senolytic support. Senescent cells, sometimes called zombie cells, stop dividing but do not die. They release inflammatory signals that damage surrounding tissue. Quercetin and certain flavonoids have been studied for their ability to selectively clear these cells. Human trials are early, but mechanistic evidence is strong.
Mitochondrial support. Coenzyme Q10, alpha lipoic acid and magnesium all play roles in mitochondrial efficiency. As mitochondria decline, cellular energy drops and oxidative stress increases. These compounds support the electron transport chain and antioxidant defence systems.
Cognitive reserve. Lion's Mane extract stimulates nerve growth factor (NGF), supporting the maintenance and growth of neurons. Ginkgo Biloba has been studied for cerebral blood flow. Cognitive decline is one of the earliest and most impactful markers of reduced healthspan.
What Does Not Work
Most of the longevity supplement market does not survive contact with the evidence. Resveratrol in capsule form has poor bioavailability unless specifically formulated. High-dose antioxidants in isolation can interfere with beneficial stress responses. Single-ingredient approaches to complex, multi-pathway processes tend to underperform.
The most consistent finding in longevity research is that interventions work better together than in isolation. The same biochemical pathways that NR supports are enhanced by resveratrol. The mitochondrial benefits of CoQ10 are amplified by adequate magnesium. Good formulation is not stacking ingredients for the label. It is choosing compounds that reinforce each other's mechanisms.
The Practical Takeaway
Longevity is not a single pill. It is a sustained practice. The evidence points toward a small set of habits and interventions that, taken consistently over years, appear to meaningfully slow the rate of age-related decline: regular exercise, adequate sleep, caloric awareness, stress regulation, and a small number of well-evidenced compounds taken daily.
Protocol 01 is built around this thinking. Not a headline ingredient with fillers. A considered combination of compounds that work on the mechanisms of ageing simultaneously, at doses that match the clinical literature.